Q2 2018 13F Holders as of 6/30/2018
-
Type / Class
-
Equity / Class A Stock
-
Shares outstanding
-
115M
-
Number of holders
-
283
-
Total 13F shares, excl. options
-
63.6M
-
Shares change
-
+2.76M
-
Total reported value, excl. options
-
$3.21B
-
Value change
-
+$142M
-
Put/Call ratio
-
1.55
-
Number of buys
-
143
-
Number of sells
-
-128
-
Price
-
$50.46
Significant Holders of GLOBUS MEDICAL INC - Class A Stock (GMED) as of Q2 2018
333 filings reported holding GMED - GLOBUS MEDICAL INC - Class A Stock as of Q2 2018.
GLOBUS MEDICAL INC - Class A Stock (GMED) has 283 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 63.6M shares
of 115M outstanding shares and own 55.23% of the company stock.
Largest 10 shareholders include BlackRock Inc. (9.2M shares), VANGUARD GROUP INC (6.52M shares), WELLINGTON MANAGEMENT GROUP LLP (5.72M shares), STATE STREET CORP (2.49M shares), AQR CAPITAL MANAGEMENT LLC (2.23M shares), Bank of New York Mellon Corp (1.63M shares), JANUS HENDERSON GROUP PLC (1.4M shares), DIMENSIONAL FUND ADVISORS LP (1.39M shares), VICTORY CAPITAL MANAGEMENT INC (1.34M shares), and MANUFACTURERS LIFE INSURANCE COMPANY, THE (1.29M shares).
This table shows the top 283 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.